Other news for: Bipolar Disorder Epilepsy Migraine Resources from HONselect First Generic Versions of Depakote Approved To treat seizures, migraines, and bipolar disorder By Scott Roberts TUESDAY, July 29 (HealthDay News) -- The first generic versions of Depakote (divalproex sodium) have been approved by the U.S. Food and Drug Administration to treat epileptic seizures, migraine headaches and bipolar disorder, the agency said Tuesday. Eight firms were granted license to produce generic versions of the brand-name drug made by Abbott Laboratories. The generics will have the same label warnings as the brand-name medication, including cautions about increased risk of severe liver damage, inflamed pancreas, and neural tube birth defects. "Generic drugs undergo a rigorous scientific review to ensure that they will provide the patient with the same amount of high quality, safe and effective drug as the name brand product," Gary Buehler, director of the FDA's Office of Generic Drugs, said in an agency news release. More information To learn more about this drug, also called valproic acid, visit the U.S. government's MedlinePlus site. Copyright © 2008 ScoutNews, LLC . All rights reserved.URL:http://www.healthscout.com/template.asp?id=617926 Resources from HONselect: HONselect is the HON's medical search engine. It retrieves scientific articles, images, conferences and web sites on the selected subject. The list of medical terms above are retrieved automatically from the article. Disclaimer: The text presented on this page is not a substitute for professional medical advice. It is for your information only and may not represent your true individual medical situation. Do not hesitate to consult your healthcare provider if you have any questions or concerns. Do not use this information to diagnose or treat a health problem or disease without consulting a qualified healthcare professional. Be advised that HealthDay articles are derived from various sources and may not reflect your own country regulations. The Health On the Net Foundation does not endorse opinions, products, or services that may appear in HealthDay articles.

Home

About us

Contact

MediaCorner

HONewsletter

Ethical policy

Site map

HON Foundation is an NGO in Special Consultative Status with the Economic and Social Council of the United Nations

/News/HSN/617926.html

Last modified:  Aug 26 2008

© HON 2008